A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
MycosesCandidiasisAspergillosisCryptococcosisBlastomycosisHistoplasmosisNeutropenia
Interventions
DRUG

ITCZ Oral Solution

ITCZ syrup product containing ITCZ 10 mg per ml in dose range of 20 ml to 40 ml daily for 7 days up to 12 weeks

DRUG

ITCZ-IV

200 mg IV twice daily for 2 days and once daily for the next 1 to 12 days

Trial Locations (1)

Unknown

Fukuoka

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY